Haematommic Acid

Haematommic Acid

SCHEMBL13495709

Cc1cc(O)c(C=O)c(O)c1C(=O)O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 9/20 1.00
MAPT P10636 7/20 1.00
USP2 O75604 4/20 0.64
PTPN1 P18031 2/20 0.54
PTGES O14684 1/20 0.54
ACHE P22303 1/20 0.48
ALDH1A1 P00352 7/20 0.48
KMT2A Q03164 7/20 0.48
MEN1 O00255 6/20 0.48
KDM4E B2RXH2 5/20 0.48
TDP1 Q9NUW8 5/20 0.48
CASP1 P29466 2/20 0.48
APP P05067 1/20 0.43
BACE1 P56817 1/20 0.43
LDHA P00338 3/20 0.41
LDHB P07195 3/20 0.41
MAPK1 P28482 5/20 0.39
HPGD P15428 5/20 0.39
POLB P06746 5/20 0.39
SMN1; SMN2 Q16637 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23728249 0.85 CYP3A4 (0.74) CYP3A4MAPTUSP2PTPN1PTGES
SCHEMBL1161853 0.85 CYP3A4 (0.74) CYP3A4MAPTUSP2PTPN1PTGES
SCHEMBL30460437 0.82 CYP3A4 (0.70) CYP3A4MAPTUSP2PTPN1PTGES
SCHEMBL29048606 0.82 CYP3A4 (0.70) CYP3A4MAPTUSP2PTPN1PTGES
Methyl Haematommate SCHEMBL28343741 0.81 CYP3A4 (0.77) CYP3A4MAPTUSP2PTPN1PTGES
SCHEMBL30669900 0.80 CYP3A4 (0.69) CYP3A4MAPTUSP2PTPN1PTGES
Ethyl Hematommate SCHEMBL12998324 0.78 CYP3A4 (1.00) CYP3A4MAPTUSP2PTPN1PTGES
Ethyl Hematommate SCHEMBL31350971 0.78 CYP3A4 (1.00) CYP3A4MAPTUSP2PTPN1PTGES
SCHEMBL19193899 0.78 CYP3A4 (0.63) CYP3A4MAPTPTPN1ACHEALDH1A1
SCHEMBL22799148 0.77 CYP3A4 (0.67) CYP3A4MAPTUSP2PTPN1PTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110568106-B Quantitative detection method for turpentine substances in turpentine plants or extracts 云南中烟工业有限责任公司 2021-08-03 CN claimed
CN-110554120-B Detection method of tree moss fragrant ester substance 云南中烟工业有限责任公司 2021-08-03 CN claimed
CN-110554120-A Detection method of tree moss aroma phenolic substances CHINA TOBACCO YUNNAN IND CO LTD 2019-12-10 CN claimed
EP-4159213-A1 PHARMACEUTICAL COMPOSITIONS FOR USE IN PREVENTION AND/OR TREATMENT AND/OR CURE OF HEPATITIS B VIRUS Katholieke Universiteit Leuven (BE) 2023-04-05 EP disclosed
CN-110568106-B Quantitative detection method for turpentine substances in turpentine plants or extracts 云南中烟工业有限责任公司 2021-08-03 CN disclosed
CN-110554120-B Detection method of tree moss fragrant ester substance 云南中烟工业有限责任公司 2021-08-03 CN disclosed
CN-110568106-A Quantitative detection method for turpentine substances in turpentine plants or extracts 云南中烟工业有限责任公司 2019-12-13 CN disclosed
CN-110554120-A Detection method of tree moss aroma phenolic substances CHINA TOBACCO YUNNAN IND CO LTD 2019-12-10 CN disclosed
US-9463195-B2 Dissolution of amyloid fibrils by flavonoids and other compounds THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-10-11 US disclosed
US-9463195-B2 Dissolution of amyloid fibrils by flavonoids and other compounds THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2016-10-11 US disclosed
US-20100048510-A1 DISSOLUTION OF AMYLOID FIBRILS BY FLAVONOIDS AND OTHER COMPOUNDS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-02-25 US disclosed
US-20100048510-A1 DISSOLUTION OF AMYLOID FIBRILS BY FLAVONOIDS AND OTHER COMPOUNDS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048510-A1 DISSOLUTION OF AMYLOID FIBRILS BY FLAVONOIDS AND OTHER COMPOUNDS B2M, APP, BACE2 CYP3A4 658/4885MAPT 49/4885USP2 1296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.